Application 219085
- Type
- ANDA
- Sponsor
- AUROBINDO PHARMA LIMITED
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LUMATEPERONE | LUMATEPERONE | CAPSULE | 42MG | No | No |
| 002 | LUMATEPERONE | LUMATEPERONE | CAPSULE | 14MG | No | No |
| 003 | LUMATEPERONE | LUMATEPERONE | CAPSULE | 28MG | No | No |
| 004 | LUMATEPERONE | LUMATEPERONE | CAPSULE | 10.5MG | No | No |
| 005 | LUMATEPERONE | LUMATEPERONE | CAPSULE | 21MG | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CAPLYTA | LUMATEPERONE | Intra-Cellular Therapies, Inc | db730b06-6351-47fd-8183-e61e61bbead5 | 2025-06-20 | Boxed warning, Warnings, Adverse reactions | LUMATEPERONE |